Elektrophysiologische Devicetherapie
Vorsitz: S. Hohnloser (Frankfurt am Main), J. O. Schwab (Bonn)
| (V170) | The “Painless Strategy” in Implantable Cardioverter Therapy: reduction of rate, length of hospitalizations, and costs in Advance III Trial. | |
| A. Kloppe, B. Lemke, A. Proclemer, A. Arenal, M. Lunati, M. Ferrer, A. Hersi, L. Manotta, M. Gasparini , ADVANCE (Bochum, Lüdenscheid; Udine, Milano, IT; Madrid, Gasteiz, ES; Riyadh, SA) | ||
| Diskussion | ||
| (V171) | Effects of Digoxin on Mortality in ICD-recipients: Results of a 10 year Follow-Up Study in 1020 Patients | |
| J. Erath, M. Vamos, H. Ackermann, S. P. Linzbach, J. Schmitt, A. Steidl, S. Hohnloser (Frankfurt am Main, Gießen) | ||
| Diskussion | ||
| (V172) | Cardiovascular and non-cardiovascular adverse events in sinus node disease and AV block with a ventricular pacing minimization mode versus standard DDD: A substudy from the ANSWER trial | |
| M. Stockburger, S. Boveda, J. Moreno, A. Dacosta, R. Hatala, J. Brachmann, C. Butter, J. Garcia Seara, M. Rolando, P. Defaye , ANSWER (Nauen, Coburg, Bernau b. Berlin; Toulouse, Saint-Etienne, Clamart, Grenoble, FR; Madrid, Santiago de Compostela, ES; Bratislava, SK) | ||
| Diskussion | ||
| (V173) | Implantable loop recorders in patients with unexplained syncope - predictors for pacemaker implantation | |
| M. Huemer, A.-K. Becker, A. Wutzler, P. Attanasio, A. S. Parwani, L.-H. Boldt, W. Haverkamp (Berlin) | ||
| Diskussion | ||
| (V174) | Keynote Lecture: State of the Art | |
| A. Bauer (München) | ||
| Diskussion |